SMS Pharmaceuticals Limited

NSEI:SMSPHARMA Stock Report

Market Cap: ₹25.0b

SMS Pharmaceuticals Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for SMS Pharmaceuticals.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth18.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

Sep 07
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be Increased To ₹0.40

Aug 22
SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be Increased To ₹0.40

Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%

Aug 20
Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

Aug 08
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

What SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 27% Share Price Gain Is Not Telling You

Jul 04
What SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 27% Share Price Gain Is Not Telling You

Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly

Jun 21
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly

SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up

Feb 29
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up

SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment

Sep 24
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment

SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30

Sep 11
SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30

Aug 28
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30

SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet

Jun 07
SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet

Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why

Sep 23
Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why

SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30

Sep 15
SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30

SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30

Sep 01
SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30

Aug 18
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30

We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt

Mar 22
We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt

SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality

Jun 03
SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality

Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?

Mar 08
Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?

What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?

Feb 22
What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?

The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It

Feb 08
The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It

SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Jan 18
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden

Dec 09
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SMS Pharmaceuticals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NSEI:SMSPHARMA - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20247,384570N/AN/AN/A
3/31/20247,093498-20501N/A
12/31/20236,129361N/AN/AN/A
9/30/20236,002288343751N/A
6/30/20235,930150N/AN/AN/A
3/31/20235,221-71-75225N/A
12/31/20224,335-42N/AN/AN/A
9/30/20224,0609-221-49N/A
6/30/20224,211259N/AN/AN/A
3/31/20225,199622178451N/A
12/31/20216,348789N/AN/AN/A
9/30/20216,612911-325815N/A
6/30/20216,172791N/AN/AN/A
3/31/20215,632625-613905N/A
12/31/20204,911458N/AN/AN/A
9/30/20204,226319-239482N/A
6/30/20204,130308N/AN/AN/A
3/31/20204,143316-30397N/A
12/31/20194,206386N/AN/AN/A
9/30/20194,412405-149330N/A
6/30/20194,606406N/AN/AN/A
3/31/20194,667400149498N/A
3/31/20184,639317N/A318N/A
3/31/20174,388285N/A735N/A
3/31/20166,032409N/A612N/A
12/31/20155,902391N/AN/AN/A
9/30/20155,828396N/AN/AN/A
6/30/20155,651343N/AN/AN/A
3/31/20155,793352N/A789N/A
12/31/20145,730358N/AN/AN/A
9/30/20145,624327N/AN/AN/A
6/30/20145,567326N/AN/AN/A
3/31/20145,180204N/A651N/A
12/31/20133,976686N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if SMSPHARMA's forecast earnings growth is above the savings rate (6.7%).

Earnings vs Market: Insufficient data to determine if SMSPHARMA's earnings are forecast to grow faster than the Indian market

High Growth Earnings: Insufficient data to determine if SMSPHARMA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if SMSPHARMA's revenue is forecast to grow faster than the Indian market.

High Growth Revenue: Insufficient data to determine if SMSPHARMA's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SMSPHARMA's Return on Equity is forecast to be high in 3 years time


Discover growth companies